Presumed risk factors and biomarkers for severe respiratory syncytial virus disease and related sequelae: Protocol for an observational multicenter, case-control study from the Respiratory Syncytial Virus Consortium in Europe (RESCEU)
Respiratory syncytial virus (RSV) is the leading viral pathogen associated with acute lower respiratory tract infection and hospitalization in children < 5 years of age worldwide. While there are known clinical risk factors for severe RSV infection, the majority of those hospitalized are previous...
Auteurs principaux: | Jefferies, K, Drysdale, SB, Robinson, H, Clutterbuck, EA, Blackwell, L, McGinley, J, Lin, G-L, Galal, U, Nair, H, Aerssens, J, Öner, D, Langedijk, A, Bont, L, Wildenbeest, JG, Martinon-Torres, F, Rodríguez-Tenreiro Sánchez, C, Nadel, S, Openshaw, P, Thwaites, R, Widjojoatmodjo, M, Zhang, L, Nguyen, TL-A, Giaquinto, C, Giordano, G, Baraldi, E, Pollard, AJ |
---|---|
Autres auteurs: | Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators |
Format: | Journal article |
Langue: | English |
Publié: |
Oxford University Press
2020
|
Documents similaires
-
Respiratory Syncytial Virus Consortium in Europe (RESCEU) birth cohort study: defining the burden of infant respiratory syncytial virus disease in Europe
par: Wildenbeest, JG, et autres
Publié: (2020) -
Clinical and viral factors associated with disease severity and subsequent wheezing in infants with respiratory syncytial virus infection
par: McGinley, JP, et autres
Publié: (2022) -
Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study
par: Korsten, K, et autres
Publié: (2021) -
A systematic review and meta-analysis of animal studies investigating the relationship between serum antibody, T lymphocytes, and respiratory syncytial virus disease
par: McGinley, J, et autres
Publié: (2021) -
A genome-wide association study of respiratory syncytial virus infection severity in infants
par: Johnson, M, et autres
Publié: (2024)